Targeting CD47: NO limit on therapeutic potential

Circ Res. 2007 Mar 16;100(5):602-3. doi: 10.1161/01.RES.0000261609.44977.25.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Review
  • Comment

MeSH terms

  • Animals
  • CD47 Antigen / genetics
  • CD47 Antigen / metabolism*
  • CD47 Antigen / physiology
  • Cyclic GMP / antagonists & inhibitors
  • Cyclic GMP / biosynthesis
  • Drug Delivery Systems / methods
  • Humans
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / genetics
  • Nitric Oxide / physiology*
  • Signal Transduction / genetics
  • Thrombospondin 1 / genetics
  • Thrombospondin 1 / metabolism
  • Thrombospondin 1 / physiology
  • Vascular Diseases / genetics
  • Vascular Diseases / metabolism*
  • Vascular Diseases / prevention & control*

Substances

  • CD47 Antigen
  • Thrombospondin 1
  • Nitric Oxide
  • Cyclic GMP